Tuesday, March 30, 2021 T Cells Recognize Recent SARS-CoV-2 Variants NIAID researchers and their colleagues examined immune cells called CD8+ T cells from the blood of 30 people who recovered from COVID-19 early in the pandemic. They found that the T-cells were able to recognize virtually all mutations in three variants of SARS-CoV-2 virus that emerged late in 2020. While larger studies are needed, the researchers note that their findings suggest that the T cell response in convalescent individuals, and most likely in vaccinees as well, are largely not affected by the mutations found in these three variants, and should offer protection against emerging variants.     National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107